Hong Kong SAR
-
Taiwan-listed agro-chemical maker Rotam Global Agrosciences is tapping the loan market for $100m to refinance debt. -
HSBC has launched a new sustainable financing programme for Hong Kong businesses, offering a cash rebate to borrowers that meet carbon emissions saving targets.
-
China’s drug developer Luye Pharma Group has launched a $300m loan into general, to back the acquisition of two antipsychotic medical products.
-
Haidilao International Holding, the Chinese hotpot chain, has covered its HK$7.6bn ($962.6m) IPO in Hong Kong thanks to a stellar line-up of cornerstone investors, said bankers leading the trade.
-
Hansoh Pharmaceutical Group is making a belated attempt to list in Hong Kong some two years after mandating banks.
-
The Asian follow-on and block markets saw two transactions in Chinese healthcare names this week that raised a total of $250m.
-
Nomura hires two in HK — Credit Suisse names north Asia syndicate head — StanChart appoints global commercial banking chief
-
Two Chinese companies, Grand Baoxin Auto Group and Xinyi Glass, are tapping the offshore loan market for new financings.
-
Hong Kong IPO hopefuls rushed to file their draft prospectuses with the city’s bourse this week, as the window closes for a launch before the end of the year.
-
Chinese technology giant Xiaomi Corp, which recently floated in a landmark IPO in Hong Kong, is seeking lenders’ approval to slash the price on a $1bn loan closed last year.
-
A number of bond issuers ventured out to the debt market on Wednesday, braving a weak market backdrop to pull off deals not just in US dollars, but also in Singapore dollars and offshore renminbi.
-
Two senior bankers have joined Nomura as managing directors on the China investment banking and Asian healthcare teams, according to two memos seen by GlobalCapital Asia.
